Skip to content

Transcranial Magnetic Stimulation for Panic Disorder Based on Implicit Emotional Regulation and Cerebellar Networks: A Randomized Double-blind Controlled Trial

Transcranial Magnetic Stimulation for Panic Disorder Based on Implicit Emotional Regulation and Cerebellar Networks: A Randomized Double-blind Controlled Trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600127699
Enrollment
Unknown
Registered
2026-07-06
Start date
2026-07-18
Completion date
Unknown
Last updated
2026-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Panic Disorder

Interventions

Dual-target group:1Hz transcranial magnetic stimulation of the right dorsolateral prefrontal cortex combined with 10Hz transcranial magnetic stimulation of the left cer
Single-target group:1Hz repetitive transcranial magnetic stimulation of the right dorsolateral prefrontal cortex combined with medication
Pseudo-stimulation group:MT Transcranial Magnetic Stimulation Combined with Medication Treatment

Sponsors

The First Affiliated Hospital of Dalian Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Meets the diagnostic criteria for panic disorder according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5). 2. No anti-anxiety treatment received; 3. Dextromanuality; 4. Good binocular vision (or corrected vision) and bilateral hearing; 5. Educational level at least equivalent to primary school; 6. Sign the informed consent form; 7. The age requirement is 18 to 60 years old.

Exclusion criteria

Exclusion criteria: 1. History of other mental disorders, such as depression, bipolar disorder, schizophrenia, etc.; 2. History of severe neurological disorders (e.g., stroke, epilepsy, Parkinson's disease) or traumatic brain injury; 3. History of major somatic diseases (e.g., hyperthyroidism, myocardial infarction, metastatic tumors, etc.); 4. History of substance abuse (e.g., drugs, alcohol, or other psychoactive substances); 5. History of benzodiazepine use; 6. Contraindications for MRI examination (e.g., claustrophobia, presence of metal objects in the body); 7. Has previously undergone electroconvulsive therapy; 8. Contraindications for transcranial magnetic stimulation (patients with metallic foreign bodies in the skull, cardiac pacemakers or cardiac stents, cochlear implants, significantly elevated intracranial pressure, risk of damage to metals or electronic devices near the stimulation coil, or those with epilepsy or a family history of epilepsy). 9. Pregnant and breastfeeding women.

Design outcomes

Primary

MeasureTime frame
Hamilton Anxiety Rating Scale (HAMA) scoring;Hamilton Depression Rating Scale (HAMD) scoring;Panic-Related Symptoms Scale (PASS) Score;Phobic Disorder Severity Scale (PDSS);

Secondary

MeasureTime frame
Implicit Beliefs about Emotions Scale (IBES) scoring;Emotion Regulation Questionnaire (ERQ) score;

Countries

China

Contacts

Public ContactZhang Bingwei

The First Affiliated Hospital of Dalian Medical University

zhangbingweidoc@163.com+86 411 8363 5963

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jul 23, 2026